Form 4: KALA BIO Director Sells Shares to Cover Tax Obligations Under Pre-Arranged Plan

KALA BIO, Inc. Director Mark T. Iwicki sold 13,227 shares of common stock on June 24, 2025, at a weighted average price of $4.01 per share, primarily to satisfy tax withholding obligations related to vested restricted stock units.

Summary

• Mark T. Iwicki, a Director of KALA BIO, Inc. (KALA), executed a sale of 13,227 shares of the company's common stock.
• The transaction took place on June 24, 2025.
• The shares were sold at a weighted average price of $4.01 per share, with individual transaction prices ranging from $3.87 to $4.12.
• This sale was conducted pursuant to a Rule 10b5-1 trading plan, which Mr. Iwicki adopted on November 9, 2020.
• The stated purpose of the sale was to cover tax withholding obligations arising from the vesting and settlement of restricted stock units (RSUs) that were granted to him on June 22, 2023.
• Following this transaction, Mr. Iwicki's beneficial ownership in KALA BIO stands at 258,433 shares, which includes 103,540 unvested restricted stock units.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While it involves insider selling, the transaction was pre-planned under a 10b5-1 plan and explicitly for tax withholding obligations related to RSU vesting. This is a routine and expected event for executives and directors receiving equity compensation, mitigating the negative implications typically associated with discretionary insider sales.

Positives

• The sale was executed under a pre-established Rule 10b5-1 trading plan, indicating a pre-determined and non-discretionary transaction, which often mitigates concerns about insider selling.
• The explicit reason for the sale was to cover tax withholding obligations related to RSU vesting, a common and routine event for executives receiving equity compensation, rather than a signal of a lack of confidence in the company's future.

Negatives

• The transaction represents a reduction in the direct beneficial ownership of common stock by a company director.
• Despite being for tax purposes, any insider selling can sometimes be perceived negatively by the market, potentially leading to short-term downward pressure or a misinterpretation of management's sentiment.

Risks

• Perception risk: Although the sale was for tax purposes and pre-planned, the market might misinterpret insider selling as a negative signal, potentially impacting investor sentiment and the company's stock price in the short term.

Future Outlook

The document does not provide explicit forward-looking statements or guidance beyond the details of the specific transaction. The sale was pre-planned under a Rule 10b5-1 plan, indicating a scheduled event rather than a discretionary one based on new outlook.

Management Comments

• "This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 9, 2020 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ('RSUs') granted on June 22, 2023."
• "The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."

Industry Context

Insider transactions, particularly those executed under Rule 10b5-1 plans for tax-related purposes, are a common occurrence across all industries for executives and directors receiving equity compensation. Such transactions are generally viewed as less indicative of management's discretionary sentiment compared to unscheduled, open-market sales.

Stakeholder Impact

• Shareholders: May perceive a slight negative signal due to insider selling, although the pre-planned nature and tax-related reason mitigate this. The transaction slightly increases the public float of shares.
• Employees, Customers, Suppliers, Creditors: No direct impact on these stakeholders is indicated by this specific filing.

Key Dates

Keywords

KALA BIO, KALA, Mark T. Iwicki, Director, Insider Trading, SEC Form 4, Stock Sale, 10b5-1 Plan, Restricted Stock Units, RSU, Tax Withholding